Medeia Therapeutics Oy

Medeia Therapeutics Oy is a drug discovery company focused on novel therapeutics for neurodegenerative diseases. Medeia’s discovery platforms are centered on the expertise of Medeia’s scientific founders in the field of molecular medicine and include programs based on both small molecule and cell therapy approaches. Medeia has partnered its lead small molecule program with Orion Corporation.

www.medeiatherapeutics.com